People · Operator
Named in public records as an officer, director or promoter · active 2009–2015 · Other Health Care, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Access Scientific Inc | — | Other Health Care | Series A | $21.4M | $80.7M | 2009 |
| Remedy Pharmaceuticals, Inc. | — | Pharmaceuticals | Series A | $18.8M | $280.7M | 2013 |
David Geliebter at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside David Geliebter on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| SVEN JACOBSON | 2 | 2 |
| DAVID M. GELIEBTER | 1 | 3 |
| James Sweeney | 1 | 3 |
| Rod Dammeyer | 1 | 3 |
| Ellis Jones | 1 | 2 |
| Morten Vigeland | 1 | 1 |
| Chad Putnam | 1 | 1 |
| Richard Pluth | 1 | 1 |
| Bill Bold | 1 | 1 |
| Steven Bierman | 1 | 1 |
| Roger Hungerford | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.